Dextera Surgical Inc (DXTR) saw its loss narrow to $3.64 million, or $0.41 a share for the quarter ended Dec. 31, 2016. In the previous year period, the company reported a loss of $4.09 million, or $0.46 a share. Revenue during the quarter grew 14.14 percent to $0.80 million from $0.70 million in the previous year period. Gross margin for the quarter stood at negative 17.65 percent as compared to a negative 27 percent for the previous year period.
Operating loss for the quarter was $3.50 million, compared with an operating loss of $3.98 million in the previous year period.
“As we begin to extend our commercial reach, we are pleased to see increasing demand for the MicroCutter 5/80 surgical stapler, both in Europe and the United States,” said Julian Nikolchev, president and Chief executive officer of Dextera Surgical Inc. “Adding sales staff in the U.S. and initiating sales in Spain in partnership with B. Braun Surgical S.A. will further raise visibility of the MicroCutter 5/80. In addition, we have expanded our efforts to explore opportunities to raise additional capital through strategic relationships or other means.”
Disclaimer: Please note that this is an auto-generated article. IRIS does not guarantee the accuracy, adequacy or completeness of any information and is not responsible for any errors or omissions or for the results obtained from the use of such information. IRIS especially states that it has no financial liability whatsoever to any user on account of the use of information provided on its website. For queries contact: [email protected]
